QURE
Price
$7.17
Change
-$0.14 (-1.92%)
Updated
Dec 8, 6:59 PM EST
78 days until earnings call
TVTX
Price
$8.64
Change
-$0.01 (-0.12%)
Updated
Dec 8, 6:59 PM EST
79 days until earnings call
Ad is loading...

Compare trend and price QURE vs TVTX

Header iconQURE vs TVTX Comparison
Open Charts QURE vs TVTXBanner chart's image
uniQure
Price$7.17
Change-$0.14 (-1.92%)
Volume$427.23K
CapitalizationN/A
Travere Therapeutics
Price$8.64
Change-$0.01 (-0.12%)
Volume$814.9K
CapitalizationN/A
View a ticker or compare two or three
QURE vs TVTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
QURE vs. TVTX commentary
Dec 10, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QURE is a StrongSell and TVTX is a Hold.

COMPARISON
Comparison
Dec 10, 2023
Stock price -- (QURE: $7.16 vs. TVTX: $8.64)
Brand notoriety: QURE and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QURE: 85% vs. TVTX: 98%
Market capitalization -- QURE: $335.64M vs. TVTX: $442.61M
QURE [@Biotechnology] is valued at $335.64M. TVTX’s [@Biotechnology] market capitalization is $442.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QURE’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • QURE’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both QURE and TVTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QURE’s TA Score shows that 6 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • QURE’s TA Score: 6 bullish, 3 bearish.
  • TVTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, QURE is a better buy in the short-term than TVTX.

Price Growth

QURE (@Biotechnology) experienced а +0.35% price change this week, while TVTX (@Biotechnology) price change was +34.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

QURE is expected to report earnings on Feb 26, 2024.

TVTX is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for QURE with price predictions.
OPEN
A.I.dvisor published
a Summary for TVTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TVTX($443M) has a higher market cap than QURE($336M). TVTX YTD gains are higher at: -58.916 vs. QURE (-68.394). QURE has higher annual earnings (EBITDA): -190.47M vs. TVTX (-260.82M). QURE (659M) and TVTX (635M) have equal amount of cash in the bank . QURE has less debt than TVTX: QURE (138M) vs TVTX (405M). TVTX has higher revenues than QURE: TVTX (232M) vs QURE (112M).
QURETVTXQURE / TVTX
Capitalization336M443M76%
EBITDA-190.47M-260.82M73%
Gain YTD-68.394-58.916116%
P/E Ratio2.68N/A-
Revenue112M232M48%
Total Cash659M635M104%
Total Debt138M405M34%
FUNDAMENTALS RATINGS
QURE vs TVTX: Fundamental Ratings
QURE
TVTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
6463
P/E GROWTH RATING
1..100
8741
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QURE's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for TVTX (77). This means that QURE’s stock grew somewhat faster than TVTX’s over the last 12 months.

QURE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TVTX (100). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

QURE's SMR Rating (97) in the Biotechnology industry is in the same range as TVTX (97). This means that QURE’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (63) in the Biotechnology industry is in the same range as QURE (64). This means that TVTX’s stock grew similarly to QURE’s over the last 12 months.

TVTX's P/E Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for QURE (87). This means that TVTX’s stock grew somewhat faster than QURE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QURETVTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
69%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 20 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTYCX38.440.21
+0.55%
Fuller & Thaler Behavioral Sm-Cp Eq C
RTDCX16.480.08
+0.49%
Russell Inv Multifactor US Equity C
DSCIX12.230.05
+0.41%
Dana Epiphany ESG Small Cap Eq Instl
REQAX44.830.08
+0.18%
Russell Inv Sustainable Equity A
AWEIX28.040.04
+0.14%
CIBC Atlas Disciplined Equity Instl

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CYTK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-0.12%
CYTK - TVTX
57%
Loosely correlated
-2.18%
GOSS - TVTX
43%
Loosely correlated
-4.63%
ICPT - TVTX
37%
Loosely correlated
N/A
VERA - TVTX
37%
Loosely correlated
-3.18%
ORMP - TVTX
35%
Loosely correlated
-0.44%
More